Search for: "Mylan Pharmaceuticals" Results 181 - 200 of 739
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Jul 2018, 2:38 pm by Jason Rantanen
Mylan Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., AKORN, Inc. [read post]
23 Jul 2018, 1:18 pm by Alex Moss
This case began when Allergan sued a number of generic pharmaceutical companies, including Mylan, for infringing its patents related to Restasis, a treatment for symptoms of chronic dry eye. [read post]
22 Jul 2018, 8:32 pm by Patent Docs
Mylan Pharmaceuticals, affirming the decision by the Patent Trial and Appeal Board (PTAB) of the U.S. [read post]
20 Jul 2018, 8:18 am by Matthew L.M. Fletcher
Mylan Pharmaceuticals: 18-1638.opinion.7-20-2018 Briefs here. [read post]
14 Jun 2018, 3:45 am by Steve Brachmann
Mylan Pharmaceuticals, a case appealed from the Patent Trial and Appeal Board (PTAB) which asks the appeals court to determine whether tribal sovereign immunity can be asserted to terminate inter partes review (IPR) proceedings at the PTAB. [read post]
14 Jun 2018, 3:45 am by Steve Brachmann
Mylan Pharmaceuticals, a case appealed from the Patent Trial and Appeal Board (PTAB) which asks the appeals court to determine whether tribal sovereign immunity can be asserted to terminate inter partes review (IPR) proceedings at the PTAB. [read post]
17 May 2018, 2:24 pm by Sabrina I. Pacifici
The list of 52 drugs are made by some of the biggest pharmaceutical companies including Novartis, Pfizer, Mylan, and Valeant “FDA is committed – among other things – to addressing and improving transparency about this and other gaming tactics that delay the generic competition Congress intended,” the agency said on Thursday. [read post]
22 Apr 2018, 8:40 am by CMS
The process of invention may not be completed by subsequent preparation of a pharmaceutical composition. [read post]
25 Feb 2018, 11:45 am
  Mylan had instituted inter partes review (IPR) proceedings against Allergan back in December 2016. [read post]
5 Feb 2018, 9:59 pm by Patent Docs
Mylan Pharmaceuticals, Inc. v. [read post]